07M Trademark

Trademark Overview

On Monday, April 17, 2023, a trademark application was filed for 07M with the United States Patent and Trademark Office. The USPTO has given the 07M trademark a serial number of 97892694. The federal status of this trademark filing is REGISTERED as of Tuesday, September 3, 2024. This trademark is owned by Gilead Sciences Ireland UC. The 07M trademark is filed in the Pharmaceutical Products category with the following description:

Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV and AIDS; pharmaceutical preparations for the treatment of autoimmune diseases and disorders
07m

General Information

Serial Number97892694
Word Mark07M
Filing DateMonday, April 17, 2023
Status700 - REGISTERED
Status DateTuesday, September 3, 2024
Registration Number7491552
Registration DateTuesday, September 3, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 18, 2024

Trademark Statements

Goods and ServicesAntiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV and AIDS; pharmaceutical preparations for the treatment of autoimmune diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 11, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGilead Sciences Ireland UC
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCarrigtohill, Co. Cork
IE
Party NameGilead Sciences Ireland UC
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCarrigtohill, Co. Cork
IE
Party NameGilead Sciences Ireland UC
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCarrigtohill, Co. Cork
IE

Trademark Events

Event DateEvent Description
Thursday, April 20, 2023NEW APPLICATION ENTERED
Thursday, May 11, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 27, 2023ASSIGNED TO EXAMINER
Wednesday, June 28, 2023NON-FINAL ACTION WRITTEN
Wednesday, June 28, 2023NON-FINAL ACTION E-MAILED
Wednesday, June 28, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 30, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, August 30, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, November 7, 2023ASSIGNED TO EXAMINER
Wednesday, December 13, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, May 5, 2024ASSIGNED TO LIE
Sunday, May 5, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, May 5, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 13, 2024ASSIGNED TO EXAMINER
Tuesday, May 14, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 14, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, May 14, 2024EXAMINERS AMENDMENT -WRITTEN
Tuesday, May 14, 2024EXAMINERS AMENDMENT E-MAILED
Tuesday, May 14, 2024EXAMINERS AMENDMENT -WRITTEN
Tuesday, May 14, 2024EXAMINERS AMENDMENT E-MAILED
Tuesday, May 14, 2024EXAMINERS AMENDMENT -WRITTEN
Tuesday, May 14, 2024EXAMINER'S AMENDMENT ENTERED
Tuesday, May 14, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, May 14, 2024EXAMINERS AMENDMENT E-MAILED
Tuesday, May 14, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, May 29, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 18, 2024PUBLISHED FOR OPPOSITION
Tuesday, June 18, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 3, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, September 3, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

pharmaceutical preparations treatment autoimmune diseases disorders aids prevention infective antiviral